Nichole Reisdorph
Concepts (660)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Metabolomics | 26 | 2025 | 727 | 4.330 |
Why?
| | Mass Spectrometry | 23 | 2025 | 750 | 2.200 |
Why?
| | Metabolome | 12 | 2023 | 384 | 1.980 |
Why?
| | Tandem Mass Spectrometry | 10 | 2023 | 576 | 1.750 |
Why?
| | Bronchoalveolar Lavage Fluid | 9 | 2024 | 636 | 1.340 |
Why?
| | Ion Mobility Spectrometry | 3 | 2020 | 5 | 1.300 |
Why?
| | Asthma | 12 | 2024 | 1767 | 1.240 |
Why?
| | Proteomics | 12 | 2019 | 1195 | 1.220 |
Why?
| | Chromatography, High Pressure Liquid | 11 | 2025 | 594 | 1.120 |
Why?
| | Proteome | 8 | 2019 | 518 | 1.120 |
Why?
| | Lipids | 6 | 2022 | 710 | 1.050 |
Why?
| | Ozone | 6 | 2025 | 132 | 1.010 |
Why?
| | Diet, Mediterranean | 2 | 2024 | 28 | 0.990 |
Why?
| | Phytochemicals | 1 | 2025 | 13 | 0.880 |
Why?
| | Tea | 1 | 2025 | 17 | 0.880 |
Why?
| | Research | 2 | 2018 | 431 | 0.850 |
Why?
| | Chromatography, Liquid | 11 | 2025 | 454 | 0.810 |
Why?
| | Biomarkers | 25 | 2024 | 4271 | 0.810 |
Why?
| | Amino Acids | 4 | 2020 | 521 | 0.790 |
Why?
| | Lung | 14 | 2025 | 4109 | 0.770 |
Why?
| | Eicosanoids | 4 | 2022 | 58 | 0.730 |
Why?
| | Blood Chemical Analysis | 3 | 2014 | 109 | 0.720 |
Why?
| | Metabolic Networks and Pathways | 5 | 2021 | 187 | 0.700 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 7 | 2022 | 920 | 0.700 |
Why?
| | Benz(a)Anthracenes | 1 | 2021 | 2 | 0.680 |
Why?
| | Benzopyrenes | 1 | 2021 | 4 | 0.680 |
Why?
| | Polycyclic Aromatic Hydrocarbons | 1 | 2021 | 29 | 0.660 |
Why?
| | Animals | 60 | 2025 | 38058 | 0.660 |
Why?
| | Mice | 42 | 2025 | 18339 | 0.640 |
Why?
| | Pneumonia | 5 | 2025 | 631 | 0.640 |
Why?
| | Liquid-Liquid Extraction | 3 | 2018 | 14 | 0.640 |
Why?
| | Docosahexaenoic Acids | 5 | 2025 | 83 | 0.630 |
Why?
| | Dietary Supplements | 8 | 2026 | 576 | 0.620 |
Why?
| | Dietary Approaches To Stop Hypertension | 1 | 2020 | 13 | 0.620 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 3 | 2026 | 179 | 0.620 |
Why?
| | Food | 2 | 2020 | 149 | 0.610 |
Why?
| | Breath Tests | 2 | 2017 | 79 | 0.600 |
Why?
| | Cardiovascular Diseases | 4 | 2024 | 2168 | 0.590 |
Why?
| | Organic Chemicals | 1 | 2020 | 127 | 0.570 |
Why?
| | Phosphopeptides | 1 | 2018 | 20 | 0.560 |
Why?
| | Peptide Mapping | 1 | 2018 | 63 | 0.560 |
Why?
| | Databases, Chemical | 1 | 2018 | 9 | 0.560 |
Why?
| | Eicosapentaenoic Acid | 3 | 2024 | 36 | 0.550 |
Why?
| | Monocytes | 1 | 2021 | 538 | 0.540 |
Why?
| | Tyrosine | 1 | 2018 | 222 | 0.530 |
Why?
| | Isotope Labeling | 1 | 2018 | 82 | 0.530 |
Why?
| | Hypersensitivity | 4 | 2022 | 252 | 0.510 |
Why?
| | Tobacco Smoke Pollution | 2 | 2017 | 233 | 0.510 |
Why?
| | Pulmonary Emphysema | 4 | 2019 | 275 | 0.510 |
Why?
| | Macrophages | 3 | 2025 | 1511 | 0.500 |
Why?
| | Smoking | 7 | 2020 | 1472 | 0.500 |
Why?
| | Skin | 3 | 2018 | 755 | 0.490 |
Why?
| | Humans | 77 | 2026 | 144759 | 0.490 |
Why?
| | Gastrointestinal Microbiome | 1 | 2025 | 771 | 0.490 |
Why?
| | Adaptor Proteins, Signal Transducing | 3 | 2018 | 427 | 0.490 |
Why?
| | Plasma | 2 | 2017 | 225 | 0.480 |
Why?
| | Mice, Inbred C57BL | 14 | 2025 | 5992 | 0.450 |
Why?
| | Gas Chromatography-Mass Spectrometry | 2 | 2020 | 131 | 0.450 |
Why?
| | Saliva | 1 | 2017 | 249 | 0.450 |
Why?
| | Glycerophospholipids | 4 | 2022 | 39 | 0.440 |
Why?
| | Nerve Tissue Proteins | 1 | 2018 | 592 | 0.430 |
Why?
| | Salmon | 2 | 2025 | 21 | 0.430 |
Why?
| | Seafood | 2 | 2025 | 26 | 0.420 |
Why?
| | Peptides | 4 | 2019 | 995 | 0.420 |
Why?
| | Computational Biology | 3 | 2020 | 680 | 0.420 |
Why?
| | Leukotriene E4 | 3 | 2013 | 24 | 0.410 |
Why?
| | Alveolar Epithelial Cells | 3 | 2019 | 120 | 0.410 |
Why?
| | Mitochondria | 5 | 2023 | 984 | 0.400 |
Why?
| | Cell Differentiation | 2 | 2021 | 2050 | 0.400 |
Why?
| | Chromatography, Reverse-Phase | 1 | 2013 | 27 | 0.390 |
Why?
| | Oxylipins | 4 | 2025 | 47 | 0.380 |
Why?
| | Microbiota | 4 | 2022 | 781 | 0.370 |
Why?
| | Bronchoalveolar Lavage | 3 | 2018 | 89 | 0.370 |
Why?
| | Niacinamide | 2 | 2026 | 86 | 0.360 |
Why?
| | Cholesterol | 3 | 2024 | 406 | 0.360 |
Why?
| | Endocannabinoids | 2 | 2022 | 57 | 0.350 |
Why?
| | Vitamins | 2 | 2025 | 178 | 0.350 |
Why?
| | Sirtuin 3 | 3 | 2023 | 60 | 0.350 |
Why?
| | Autoantigens | 4 | 2019 | 429 | 0.350 |
Why?
| | Software | 4 | 2020 | 690 | 0.350 |
Why?
| | Male | 45 | 2026 | 72315 | 0.340 |
Why?
| | Liver | 4 | 2020 | 1887 | 0.330 |
Why?
| | Reproducibility of Results | 7 | 2020 | 3409 | 0.320 |
Why?
| | Fatty Acids, Omega-3 | 2 | 2022 | 142 | 0.320 |
Why?
| | Sleep Deprivation | 2 | 2023 | 206 | 0.310 |
Why?
| | Transcriptome | 4 | 2022 | 1045 | 0.300 |
Why?
| | Immunoenzyme Techniques | 1 | 2009 | 200 | 0.290 |
Why?
| | Species Specificity | 2 | 2020 | 574 | 0.290 |
Why?
| | Analgesia | 1 | 2010 | 105 | 0.290 |
Why?
| | Blood Pressure | 5 | 2026 | 1769 | 0.280 |
Why?
| | Kainic Acid | 2 | 2018 | 33 | 0.260 |
Why?
| | Diet | 4 | 2024 | 1273 | 0.260 |
Why?
| | Female | 40 | 2026 | 78271 | 0.260 |
Why?
| | Minerals | 2 | 2025 | 47 | 0.260 |
Why?
| | Sensitivity and Specificity | 5 | 2017 | 1985 | 0.260 |
Why?
| | Workflow | 2 | 2020 | 184 | 0.260 |
Why?
| | Interleukin-13 | 3 | 2024 | 144 | 0.260 |
Why?
| | Urinalysis | 2 | 2020 | 80 | 0.260 |
Why?
| | Cell Line | 8 | 2025 | 2882 | 0.250 |
Why?
| | RNA, Ribosomal, 16S | 3 | 2025 | 558 | 0.250 |
Why?
| | Chromatography, Ion Exchange | 1 | 2007 | 57 | 0.250 |
Why?
| | Inflammation Mediators | 2 | 2020 | 509 | 0.250 |
Why?
| | Mitochondrial Proteins | 2 | 2019 | 262 | 0.250 |
Why?
| | Pyrrolidines | 2 | 2025 | 125 | 0.250 |
Why?
| | Obesity | 7 | 2024 | 3077 | 0.240 |
Why?
| | Disease Models, Animal | 9 | 2025 | 4557 | 0.240 |
Why?
| | Pilot Projects | 7 | 2026 | 1886 | 0.240 |
Why?
| | Amnesia | 1 | 2026 | 47 | 0.240 |
Why?
| | Middle Aged | 20 | 2025 | 35875 | 0.240 |
Why?
| | Mucus | 2 | 2024 | 73 | 0.240 |
Why?
| | Ions | 1 | 2026 | 71 | 0.240 |
Why?
| | Data Interpretation, Statistical | 2 | 2018 | 372 | 0.230 |
Why?
| | Receptors, Lipoxin | 1 | 2025 | 6 | 0.230 |
Why?
| | Pulmonary Medicine | 1 | 2006 | 79 | 0.230 |
Why?
| | Dermatitis, Atopic | 3 | 2018 | 321 | 0.230 |
Why?
| | Phenylpropionates | 1 | 2025 | 27 | 0.230 |
Why?
| | Food Analysis | 1 | 2025 | 24 | 0.230 |
Why?
| | Diet, High-Fat | 3 | 2022 | 261 | 0.230 |
Why?
| | Body Fluids | 2 | 2017 | 70 | 0.230 |
Why?
| | Receptors, Formyl Peptide | 1 | 2025 | 17 | 0.230 |
Why?
| | Sodium Nitrite | 2 | 2015 | 39 | 0.230 |
Why?
| | Fish Products | 1 | 2025 | 7 | 0.230 |
Why?
| | Laboratories | 1 | 2026 | 109 | 0.220 |
Why?
| | Receptors, G-Protein-Coupled | 3 | 2021 | 233 | 0.220 |
Why?
| | Germ-Free Life | 1 | 2025 | 33 | 0.220 |
Why?
| | Fetal Growth Retardation | 2 | 2021 | 587 | 0.220 |
Why?
| | Metals, Heavy | 1 | 2025 | 31 | 0.220 |
Why?
| | Flavoproteins | 1 | 2004 | 8 | 0.210 |
Why?
| | Photoreceptor Cells, Invertebrate | 1 | 2004 | 4 | 0.210 |
Why?
| | Chlamydomonas reinhardtii | 1 | 2004 | 8 | 0.210 |
Why?
| | Membrane Microdomains | 1 | 2024 | 34 | 0.210 |
Why?
| | Ethanol | 2 | 2019 | 627 | 0.210 |
Why?
| | Fatty Acids, Unsaturated | 2 | 2022 | 98 | 0.210 |
Why?
| | Agaricus | 1 | 2023 | 3 | 0.210 |
Why?
| | Lectins | 1 | 2024 | 44 | 0.210 |
Why?
| | CD4-Positive T-Lymphocytes | 3 | 2016 | 1129 | 0.210 |
Why?
| | GPI-Linked Proteins | 1 | 2024 | 80 | 0.210 |
Why?
| | Solid Phase Extraction | 2 | 2014 | 25 | 0.200 |
Why?
| | Mucin 5AC | 1 | 2024 | 70 | 0.200 |
Why?
| | Islet Amyloid Polypeptide | 2 | 2016 | 48 | 0.200 |
Why?
| | Bronchi | 1 | 2025 | 267 | 0.200 |
Why?
| | Benzodioxoles | 1 | 2025 | 158 | 0.200 |
Why?
| | Feces | 2 | 2025 | 513 | 0.200 |
Why?
| | Eye Proteins | 1 | 2004 | 90 | 0.200 |
Why?
| | Oxadiazoles | 1 | 2003 | 37 | 0.200 |
Why?
| | Pyridines | 2 | 2025 | 605 | 0.200 |
Why?
| | Proteins | 3 | 2017 | 1021 | 0.200 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2020 | 143 | 0.200 |
Why?
| | Mice, Knockout | 10 | 2025 | 3121 | 0.200 |
Why?
| | Sleep | 4 | 2023 | 901 | 0.200 |
Why?
| | Immunoglobulin Fab Fragments | 1 | 2003 | 56 | 0.200 |
Why?
| | Isoxazoles | 1 | 2003 | 53 | 0.200 |
Why?
| | Rhinovirus | 1 | 2003 | 57 | 0.190 |
Why?
| | Quinolones | 1 | 2025 | 201 | 0.190 |
Why?
| | Epithelial Cells | 3 | 2025 | 1125 | 0.190 |
Why?
| | Plant Extracts | 1 | 2025 | 187 | 0.190 |
Why?
| | Capsid | 1 | 2003 | 94 | 0.190 |
Why?
| | Aminophenols | 1 | 2025 | 201 | 0.190 |
Why?
| | NAD | 2 | 2026 | 81 | 0.190 |
Why?
| | Arachidonic Acids | 1 | 2022 | 43 | 0.190 |
Why?
| | Acylation | 2 | 2019 | 30 | 0.180 |
Why?
| | Prostaglandins | 2 | 2022 | 94 | 0.180 |
Why?
| | Cells, Cultured | 6 | 2021 | 4154 | 0.180 |
Why?
| | Acute Lung Injury | 1 | 2025 | 303 | 0.180 |
Why?
| | Myocardium | 3 | 2019 | 939 | 0.180 |
Why?
| | Drosophila Proteins | 1 | 2004 | 212 | 0.180 |
Why?
| | Lipoxins | 1 | 2021 | 10 | 0.180 |
Why?
| | Oxidative Stress | 4 | 2021 | 1339 | 0.180 |
Why?
| | Linear Models | 2 | 2018 | 854 | 0.180 |
Why?
| | NAD(P)H Dehydrogenase (Quinone) | 2 | 2020 | 34 | 0.180 |
Why?
| | Citrate (si)-Synthase | 1 | 2021 | 57 | 0.180 |
Why?
| | Pyrazoles | 1 | 2025 | 509 | 0.170 |
Why?
| | Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2025 | 370 | 0.170 |
Why?
| | Bacterial Toxins | 1 | 2022 | 109 | 0.170 |
Why?
| | Indoles | 1 | 2025 | 501 | 0.170 |
Why?
| | Dinoprostone | 1 | 2022 | 178 | 0.170 |
Why?
| | Hippocampus | 2 | 2018 | 965 | 0.170 |
Why?
| | Orthomyxoviridae Infections | 2 | 2024 | 72 | 0.170 |
Why?
| | Brain Chemistry | 1 | 2021 | 116 | 0.170 |
Why?
| | Liver Diseases, Alcoholic | 2 | 2019 | 97 | 0.170 |
Why?
| | Insulin-Secreting Cells | 3 | 2020 | 388 | 0.170 |
Why?
| | Quantitative Trait Loci | 2 | 2021 | 374 | 0.170 |
Why?
| | Calcifediol | 2 | 2022 | 31 | 0.170 |
Why?
| | Influenza A Virus, H1N1 Subtype | 1 | 2022 | 157 | 0.170 |
Why?
| | tat Gene Products, Human Immunodeficiency Virus | 1 | 2021 | 25 | 0.170 |
Why?
| | Sepsis | 1 | 2007 | 640 | 0.170 |
Why?
| | Receptors, Scavenger | 1 | 2021 | 22 | 0.170 |
Why?
| | Amidohydrolases | 1 | 2021 | 32 | 0.170 |
Why?
| | Macrophages, Alveolar | 1 | 2024 | 368 | 0.170 |
Why?
| | Sleep Disorders, Circadian Rhythm | 1 | 2021 | 52 | 0.170 |
Why?
| | Neuroprotection | 1 | 2021 | 46 | 0.160 |
Why?
| | Phosphatidylinositol 4,5-Diphosphate | 1 | 2020 | 32 | 0.160 |
Why?
| | Vitamin D Deficiency | 1 | 2022 | 186 | 0.160 |
Why?
| | Leukocytes, Mononuclear | 4 | 2022 | 573 | 0.160 |
Why?
| | Fatty Acids, Omega-6 | 1 | 2020 | 48 | 0.160 |
Why?
| | Lipid Metabolism | 3 | 2018 | 527 | 0.160 |
Why?
| | Cognitive Dysfunction | 1 | 2026 | 461 | 0.160 |
Why?
| | Nasal Polyps | 1 | 2020 | 59 | 0.160 |
Why?
| | Vital Capacity | 2 | 2018 | 290 | 0.160 |
Why?
| | Melatonin | 1 | 2021 | 163 | 0.160 |
Why?
| | Vesicular Transport Proteins | 1 | 2020 | 86 | 0.160 |
Why?
| | Phosphorylation | 4 | 2019 | 1732 | 0.160 |
Why?
| | Biotransformation | 1 | 2020 | 63 | 0.160 |
Why?
| | Phosphatidylcholines | 1 | 2020 | 131 | 0.160 |
Why?
| | Aged | 12 | 2026 | 25913 | 0.150 |
Why?
| | Neuroprotective Agents | 1 | 2021 | 143 | 0.150 |
Why?
| | Succinic Acid | 1 | 2019 | 42 | 0.150 |
Why?
| | Anti-Citrullinated Protein Antibodies | 1 | 2021 | 126 | 0.150 |
Why?
| | Protein Deglycase DJ-1 | 1 | 2019 | 15 | 0.150 |
Why?
| | Umbilical Arteries | 1 | 2020 | 52 | 0.150 |
Why?
| | Myofibrils | 1 | 2019 | 49 | 0.150 |
Why?
| | Cross-Over Studies | 2 | 2020 | 601 | 0.150 |
Why?
| | Tubulin | 1 | 2020 | 147 | 0.150 |
Why?
| | Hyperinsulinism | 1 | 2020 | 113 | 0.150 |
Why?
| | Anthracenes | 1 | 2019 | 31 | 0.150 |
Why?
| | Lung Injury | 1 | 2022 | 237 | 0.150 |
Why?
| | Epithelium | 1 | 2020 | 314 | 0.150 |
Why?
| | Uterine Artery | 1 | 2020 | 75 | 0.150 |
Why?
| | Islets of Langerhans | 2 | 2019 | 833 | 0.150 |
Why?
| | Bariatric Surgery | 1 | 2022 | 242 | 0.150 |
Why?
| | Fluorenes | 1 | 2019 | 46 | 0.140 |
Why?
| | Insulin | 3 | 2022 | 2507 | 0.140 |
Why?
| | DNA End-Joining Repair | 1 | 2019 | 22 | 0.140 |
Why?
| | Inhalation Exposure | 2 | 2021 | 115 | 0.140 |
Why?
| | Rhinitis | 1 | 2020 | 171 | 0.140 |
Why?
| | Neurodegenerative Diseases | 1 | 2021 | 151 | 0.140 |
Why?
| | Liposomes | 1 | 2020 | 250 | 0.140 |
Why?
| | Dietary Proteins | 1 | 2020 | 136 | 0.140 |
Why?
| | Aging | 3 | 2023 | 1966 | 0.140 |
Why?
| | Trypsin | 1 | 2018 | 76 | 0.140 |
Why?
| | Synapses | 1 | 2022 | 439 | 0.140 |
Why?
| | Spleen | 1 | 2020 | 508 | 0.140 |
Why?
| | Excitatory Amino Acid Agonists | 1 | 2018 | 42 | 0.140 |
Why?
| | Leukotrienes | 1 | 2018 | 27 | 0.140 |
Why?
| | Gene Expression | 4 | 2020 | 1490 | 0.140 |
Why?
| | B-Lymphocyte Subsets | 1 | 2018 | 80 | 0.140 |
Why?
| | C-Peptide | 2 | 2016 | 189 | 0.140 |
Why?
| | Cysteine | 1 | 2019 | 210 | 0.140 |
Why?
| | Microtubules | 1 | 2020 | 286 | 0.140 |
Why?
| | Epilepsy, Temporal Lobe | 1 | 2018 | 37 | 0.140 |
Why?
| | Sinusitis | 1 | 2020 | 228 | 0.140 |
Why?
| | Bacteria | 1 | 2025 | 889 | 0.140 |
Why?
| | Limit of Detection | 1 | 2018 | 97 | 0.130 |
Why?
| | Adult | 15 | 2025 | 40449 | 0.130 |
Why?
| | Diet, Ketogenic | 1 | 2018 | 37 | 0.130 |
Why?
| | Myocardial Ischemia | 1 | 2019 | 285 | 0.130 |
Why?
| | Flow Injection Analysis | 1 | 2017 | 6 | 0.130 |
Why?
| | Fatty Acids, Essential | 1 | 2017 | 2 | 0.130 |
Why?
| | Inflammasomes | 1 | 2018 | 146 | 0.130 |
Why?
| | Kynurenine | 1 | 2018 | 114 | 0.130 |
Why?
| | Adiponectin | 2 | 2022 | 244 | 0.130 |
Why?
| | Sample Size | 1 | 2017 | 123 | 0.130 |
Why?
| | Health | 1 | 2017 | 81 | 0.130 |
Why?
| | Hydrolases | 1 | 2017 | 55 | 0.130 |
Why?
| | Interleukin-6 | 2 | 2021 | 780 | 0.130 |
Why?
| | Single-Cell Analysis | 1 | 2020 | 358 | 0.120 |
Why?
| | Nerve Growth Factors | 1 | 2017 | 78 | 0.120 |
Why?
| | Influenza, Human | 1 | 2022 | 616 | 0.120 |
Why?
| | Immunophenotyping | 2 | 2018 | 322 | 0.120 |
Why?
| | Disease | 1 | 2017 | 98 | 0.120 |
Why?
| | Proline | 1 | 2017 | 83 | 0.120 |
Why?
| | Antibodies | 1 | 2018 | 401 | 0.120 |
Why?
| | Autoimmunity | 2 | 2021 | 926 | 0.120 |
Why?
| | Sphingolipids | 1 | 2017 | 83 | 0.120 |
Why?
| | Artifacts | 1 | 2017 | 139 | 0.120 |
Why?
| | Hyperglycemia | 1 | 2020 | 375 | 0.120 |
Why?
| | Actins | 1 | 2018 | 425 | 0.120 |
Why?
| | Immunity, Humoral | 1 | 2017 | 120 | 0.120 |
Why?
| | Epitopes | 2 | 2016 | 485 | 0.120 |
Why?
| | Emphysema | 2 | 2013 | 100 | 0.120 |
Why?
| | Cardiomyopathies | 1 | 2019 | 338 | 0.120 |
Why?
| | Apoptosis | 4 | 2017 | 2430 | 0.120 |
Why?
| | Acetylation | 3 | 2023 | 252 | 0.120 |
Why?
| | Sex Characteristics | 1 | 2021 | 790 | 0.120 |
Why?
| | HEK293 Cells | 1 | 2018 | 744 | 0.120 |
Why?
| | High-Throughput Screening Assays | 1 | 2017 | 175 | 0.120 |
Why?
| | Cytokines | 4 | 2025 | 2061 | 0.120 |
Why?
| | Vascular Stiffness | 2 | 2018 | 486 | 0.120 |
Why?
| | Electrophoresis, Gel, Two-Dimensional | 3 | 2011 | 110 | 0.120 |
Why?
| | Arginine | 1 | 2017 | 262 | 0.110 |
Why?
| | Epitopes, T-Lymphocyte | 1 | 2016 | 175 | 0.110 |
Why?
| | Signal Transduction | 4 | 2022 | 5226 | 0.110 |
Why?
| | Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2015 | 33 | 0.110 |
Why?
| | Amino Acid Sequence | 5 | 2016 | 2155 | 0.110 |
Why?
| | Glycosphingolipids | 1 | 2015 | 7 | 0.110 |
Why?
| | Electrophysiology | 1 | 2015 | 218 | 0.110 |
Why?
| | Endoplasmic Reticulum | 1 | 2017 | 266 | 0.110 |
Why?
| | Respiratory Mucosa | 2 | 2024 | 322 | 0.110 |
Why?
| | Metabolic Syndrome | 1 | 2018 | 354 | 0.110 |
Why?
| | Aorta | 2 | 2015 | 429 | 0.110 |
Why?
| | Forensic Sciences | 1 | 2014 | 6 | 0.110 |
Why?
| | Chlorine | 1 | 2015 | 64 | 0.110 |
Why?
| | Brain | 2 | 2018 | 2933 | 0.110 |
Why?
| | Patch-Clamp Techniques | 1 | 2015 | 289 | 0.110 |
Why?
| | Diabetes Mellitus, Experimental | 1 | 2016 | 198 | 0.110 |
Why?
| | Carotid Arteries | 1 | 2015 | 207 | 0.110 |
Why?
| | Aged, 80 and over | 4 | 2026 | 8265 | 0.100 |
Why?
| | Cerebrospinal Fluid | 1 | 2014 | 88 | 0.100 |
Why?
| | Interleukin-16 | 1 | 2013 | 6 | 0.100 |
Why?
| | Insulin Resistance | 1 | 2022 | 1241 | 0.100 |
Why?
| | Lipopolysaccharides | 2 | 2025 | 863 | 0.100 |
Why?
| | Leukotriene Antagonists | 1 | 2013 | 23 | 0.100 |
Why?
| | Gangliosides | 1 | 2013 | 23 | 0.100 |
Why?
| | Cholesterol Side-Chain Cleavage Enzyme | 1 | 2013 | 9 | 0.100 |
Why?
| | Up-Regulation | 2 | 2019 | 851 | 0.100 |
Why?
| | Education | 1 | 2013 | 104 | 0.100 |
Why?
| | Methyl Ethers | 1 | 2013 | 19 | 0.100 |
Why?
| | Adrenergic beta-Agonists | 1 | 2013 | 92 | 0.100 |
Why?
| | Lung Diseases | 2 | 2013 | 787 | 0.100 |
Why?
| | Smoking Cessation | 1 | 2017 | 439 | 0.100 |
Why?
| | Methanol | 1 | 2013 | 46 | 0.100 |
Why?
| | Diabetes Mellitus, Type 1 | 4 | 2019 | 3890 | 0.100 |
Why?
| | Health Status | 1 | 2018 | 836 | 0.100 |
Why?
| | Pyridinium Compounds | 2 | 2026 | 31 | 0.090 |
Why?
| | Case-Control Studies | 2 | 2018 | 3604 | 0.090 |
Why?
| | Bronchodilator Agents | 1 | 2013 | 182 | 0.090 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 1 | 2013 | 192 | 0.090 |
Why?
| | Nasal Mucosa | 2 | 2024 | 112 | 0.090 |
Why?
| | Alcohol Drinking | 1 | 2019 | 826 | 0.090 |
Why?
| | Hydroxyeicosatetraenoic Acids | 2 | 2022 | 35 | 0.090 |
Why?
| | Arthritis, Rheumatoid | 1 | 2021 | 1169 | 0.090 |
Why?
| | Mice, Inbred NOD | 4 | 2016 | 610 | 0.090 |
Why?
| | Epilepsy | 1 | 2016 | 376 | 0.090 |
Why?
| | Double-Blind Method | 3 | 2026 | 2029 | 0.090 |
Why?
| | Heart Diseases | 1 | 2015 | 349 | 0.090 |
Why?
| | B-Lymphocytes | 1 | 2017 | 876 | 0.090 |
Why?
| | Oxidation-Reduction | 3 | 2020 | 1087 | 0.090 |
Why?
| | Molecular Sequence Data | 4 | 2016 | 2930 | 0.090 |
Why?
| | Muscle, Skeletal | 1 | 2021 | 1795 | 0.090 |
Why?
| | Calcium | 1 | 2017 | 1183 | 0.080 |
Why?
| | Fatty Acids | 3 | 2018 | 450 | 0.080 |
Why?
| | fas Receptor | 1 | 2011 | 92 | 0.080 |
Why?
| | Kaposi Varicelliform Eruption | 1 | 2011 | 21 | 0.080 |
Why?
| | Ovarian Follicle | 1 | 2011 | 73 | 0.080 |
Why?
| | Nuclear Magnetic Resonance, Biomolecular | 1 | 2013 | 346 | 0.080 |
Why?
| | Anti-Asthmatic Agents | 1 | 2013 | 251 | 0.080 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 2 | 2018 | 331 | 0.080 |
Why?
| | Motor Activity | 1 | 2015 | 721 | 0.080 |
Why?
| | Pregnancy | 5 | 2025 | 7190 | 0.080 |
Why?
| | Aluminum | 1 | 2010 | 43 | 0.080 |
Why?
| | Mice, Obese | 2 | 2021 | 66 | 0.080 |
Why?
| | Rats | 4 | 2022 | 5597 | 0.080 |
Why?
| | Pneumonia, Mycoplasma | 1 | 2010 | 55 | 0.080 |
Why?
| | Dietary Fats | 2 | 2022 | 314 | 0.080 |
Why?
| | Sarcomeres | 1 | 2010 | 98 | 0.080 |
Why?
| | E2F2 Transcription Factor | 1 | 2009 | 14 | 0.080 |
Why?
| | Phosphopyruvate Hydratase | 1 | 2009 | 26 | 0.080 |
Why?
| | Toll-Like Receptor 2 | 1 | 2010 | 126 | 0.080 |
Why?
| | Chromogranin A | 1 | 2010 | 43 | 0.080 |
Why?
| | Light | 2 | 2021 | 411 | 0.080 |
Why?
| | Gene Expression Regulation | 3 | 2015 | 2608 | 0.080 |
Why?
| | Ovary | 1 | 2011 | 228 | 0.080 |
Why?
| | Lymphocyte Activation | 3 | 2018 | 1126 | 0.070 |
Why?
| | Fatty Acid-Binding Proteins | 1 | 2009 | 79 | 0.070 |
Why?
| | Adjuvants, Immunologic | 1 | 2010 | 245 | 0.070 |
Why?
| | Endothelium, Vascular | 1 | 2015 | 965 | 0.070 |
Why?
| | Protein C | 1 | 2009 | 53 | 0.070 |
Why?
| | Binding Sites | 2 | 2020 | 1329 | 0.070 |
Why?
| | Glycoproteins | 1 | 2010 | 355 | 0.070 |
Why?
| | Sphingomyelins | 2 | 2020 | 22 | 0.070 |
Why?
| | Muscle Proteins | 1 | 2010 | 244 | 0.070 |
Why?
| | Group IV Phospholipases A2 | 2 | 2019 | 46 | 0.070 |
Why?
| | Phosphoproteins | 1 | 2010 | 344 | 0.070 |
Why?
| | Sirtuins | 2 | 2019 | 50 | 0.070 |
Why?
| | Vasoconstriction | 1 | 2009 | 217 | 0.070 |
Why?
| | Reactive Oxygen Species | 2 | 2023 | 621 | 0.070 |
Why?
| | Interleukin-1beta | 2 | 2021 | 395 | 0.070 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2022 | 2583 | 0.070 |
Why?
| | Glucose | 2 | 2023 | 1047 | 0.070 |
Why?
| | Transcriptional Activation | 1 | 2009 | 383 | 0.070 |
Why?
| | Inflammation | 3 | 2024 | 2878 | 0.060 |
Why?
| | Diet, Western | 2 | 2018 | 86 | 0.060 |
Why?
| | Rats, Sprague-Dawley | 3 | 2018 | 2527 | 0.060 |
Why?
| | Pulmonary Fibrosis | 1 | 2011 | 395 | 0.060 |
Why?
| | Child | 6 | 2024 | 22633 | 0.060 |
Why?
| | Polymorphism, Single Nucleotide | 3 | 2021 | 2145 | 0.060 |
Why?
| | Biomedical Research | 1 | 2013 | 710 | 0.060 |
Why?
| | Cognition | 1 | 2015 | 1266 | 0.060 |
Why?
| | Disease Susceptibility | 2 | 2019 | 348 | 0.060 |
Why?
| | Phenotype | 4 | 2018 | 3162 | 0.060 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2013 | 917 | 0.060 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2008 | 364 | 0.060 |
Why?
| | Curriculum | 1 | 2013 | 1059 | 0.060 |
Why?
| | Pulmonary Alveoli | 1 | 2009 | 383 | 0.060 |
Why?
| | Staphylococcal Infections | 1 | 2011 | 388 | 0.060 |
Why?
| | Exercise | 1 | 2018 | 2201 | 0.060 |
Why?
| | Heart Failure | 1 | 2019 | 2323 | 0.060 |
Why?
| | Peptide Fragments | 1 | 2010 | 699 | 0.060 |
Why?
| | Animal Feed | 1 | 2025 | 53 | 0.060 |
Why?
| | Fibroblasts | 1 | 2011 | 1034 | 0.060 |
Why?
| | Xanthophylls | 1 | 2025 | 19 | 0.060 |
Why?
| | Isomerism | 1 | 2025 | 57 | 0.060 |
Why?
| | Iodine | 1 | 2025 | 26 | 0.060 |
Why?
| | Mice, Inbred BALB C | 2 | 2019 | 1253 | 0.060 |
Why?
| | Food Handling | 1 | 2025 | 63 | 0.060 |
Why?
| | Algal Proteins | 1 | 2004 | 6 | 0.050 |
Why?
| | Drug Combinations | 1 | 2025 | 390 | 0.050 |
Why?
| | Multienzyme Complexes | 1 | 2004 | 67 | 0.050 |
Why?
| | Cysteine Endopeptidases | 1 | 2004 | 73 | 0.050 |
Why?
| | Choline | 1 | 2025 | 136 | 0.050 |
Why?
| | Gene Deletion | 1 | 2025 | 389 | 0.050 |
Why?
| | Cryptochromes | 1 | 2004 | 25 | 0.050 |
Why?
| | Antigen-Antibody Reactions | 1 | 2003 | 50 | 0.050 |
Why?
| | Cerebrovascular Circulation | 1 | 2026 | 280 | 0.050 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 2 | 2019 | 266 | 0.050 |
Why?
| | Oxazoles | 1 | 2003 | 48 | 0.050 |
Why?
| | Down-Regulation | 2 | 2020 | 627 | 0.050 |
Why?
| | Protoplasts | 1 | 2003 | 7 | 0.050 |
Why?
| | Quality Control | 1 | 2023 | 163 | 0.050 |
Why?
| | Protein Binding | 2 | 2020 | 2273 | 0.050 |
Why?
| | RNA, Small Interfering | 2 | 2018 | 635 | 0.050 |
Why?
| | Enzyme Activation | 2 | 2019 | 766 | 0.050 |
Why?
| | Cholesterol, HDL | 1 | 2023 | 200 | 0.050 |
Why?
| | Introns | 1 | 2004 | 254 | 0.050 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2004 | 159 | 0.050 |
Why?
| | Cannabinoid Receptor Modulators | 1 | 2022 | 9 | 0.050 |
Why?
| | Polyunsaturated Alkamides | 1 | 2022 | 8 | 0.050 |
Why?
| | Microscopy, Electron | 1 | 2003 | 415 | 0.050 |
Why?
| | Receptors, Cannabinoid | 1 | 2022 | 14 | 0.050 |
Why?
| | Exons | 1 | 2004 | 358 | 0.050 |
Why?
| | Virus Assembly | 1 | 2003 | 81 | 0.050 |
Why?
| | National Institute of Allergy and Infectious Diseases (U.S.) | 1 | 2022 | 25 | 0.050 |
Why?
| | Recombinant Proteins | 2 | 2020 | 1370 | 0.050 |
Why?
| | Young Adult | 5 | 2020 | 14105 | 0.050 |
Why?
| | Receptor, Cannabinoid, CB1 | 1 | 2022 | 39 | 0.050 |
Why?
| | Patient Acuity | 1 | 2022 | 47 | 0.050 |
Why?
| | Seeds | 1 | 2003 | 74 | 0.050 |
Why?
| | Protein Isoforms | 1 | 2004 | 402 | 0.050 |
Why?
| | Mutation | 2 | 2004 | 4089 | 0.050 |
Why?
| | Cholecalciferol | 1 | 2022 | 60 | 0.050 |
Why?
| | Diet, Carbohydrate-Restricted | 1 | 2022 | 37 | 0.050 |
Why?
| | Cell Line, Tumor | 2 | 2020 | 3540 | 0.040 |
Why?
| | Receptors, Antigen, B-Cell | 1 | 2022 | 134 | 0.040 |
Why?
| | HeLa Cells | 1 | 2003 | 650 | 0.040 |
Why?
| | Membrane Proteins | 1 | 2008 | 1166 | 0.040 |
Why?
| | Dietary Carbohydrates | 1 | 2022 | 151 | 0.040 |
Why?
| | Immunity | 1 | 2022 | 139 | 0.040 |
Why?
| | Polymorphism, Genetic | 1 | 2024 | 612 | 0.040 |
Why?
| | Neuropsychological Tests | 1 | 2026 | 1134 | 0.040 |
Why?
| | Cattle | 1 | 2024 | 1000 | 0.040 |
Why?
| | Protein Conformation, beta-Strand | 1 | 2020 | 19 | 0.040 |
Why?
| | 3T3-L1 Cells | 1 | 2020 | 36 | 0.040 |
Why?
| | Leptin | 1 | 2022 | 245 | 0.040 |
Why?
| | Adolescent | 4 | 2020 | 22428 | 0.040 |
Why?
| | Phosphatidylinositols | 1 | 2020 | 57 | 0.040 |
Why?
| | Phosphatidylserines | 1 | 2020 | 60 | 0.040 |
Why?
| | Prescriptions | 1 | 2021 | 76 | 0.040 |
Why?
| | Adenosine | 1 | 2022 | 255 | 0.040 |
Why?
| | Sirtuin 2 | 1 | 2020 | 27 | 0.040 |
Why?
| | Oxidative Phosphorylation | 1 | 2021 | 210 | 0.040 |
Why?
| | Glutamic Acid | 1 | 2022 | 251 | 0.040 |
Why?
| | Phosphatidylethanolamines | 1 | 2020 | 76 | 0.040 |
Why?
| | Receptors, Chemokine | 1 | 2020 | 47 | 0.040 |
Why?
| | Molecular Docking Simulation | 1 | 2020 | 124 | 0.040 |
Why?
| | Metaplasia | 1 | 2020 | 57 | 0.040 |
Why?
| | Neurons | 2 | 2023 | 1640 | 0.040 |
Why?
| | Longitudinal Studies | 2 | 2022 | 2947 | 0.040 |
Why?
| | Placental Insufficiency | 1 | 2021 | 125 | 0.040 |
Why?
| | Adipose Tissue, White | 1 | 2020 | 43 | 0.040 |
Why?
| | Muscle Fibers, Skeletal | 1 | 2021 | 214 | 0.040 |
Why?
| | Sex Factors | 2 | 2018 | 2112 | 0.040 |
Why?
| | Synaptic Transmission | 1 | 2022 | 290 | 0.040 |
Why?
| | Triglycerides | 1 | 2022 | 520 | 0.040 |
Why?
| | Calcium Signaling | 2 | 2015 | 251 | 0.040 |
Why?
| | Interleukin-8 | 1 | 2021 | 271 | 0.040 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2020 | 148 | 0.040 |
Why?
| | Nutritional Physiological Phenomena | 1 | 2020 | 55 | 0.040 |
Why?
| | Nutritional Sciences | 1 | 2020 | 38 | 0.040 |
Why?
| | Lipid Bilayers | 1 | 2020 | 103 | 0.040 |
Why?
| | Cohort Studies | 2 | 2021 | 5960 | 0.040 |
Why?
| | Cloning, Molecular | 1 | 2020 | 540 | 0.040 |
Why?
| | Water | 1 | 2003 | 469 | 0.040 |
Why?
| | Neutrophils | 1 | 2025 | 1134 | 0.040 |
Why?
| | Pregnancy Trimester, Third | 1 | 2020 | 115 | 0.040 |
Why?
| | Cellular Reprogramming | 1 | 2020 | 103 | 0.040 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2020 | 120 | 0.040 |
Why?
| | Genetic Predisposition to Disease | 2 | 2021 | 2363 | 0.040 |
Why?
| | Piperidines | 1 | 2021 | 217 | 0.040 |
Why?
| | Ultrasonography, Doppler | 1 | 2020 | 126 | 0.040 |
Why?
| | Genetic Vectors | 1 | 2020 | 337 | 0.040 |
Why?
| | Vitamin D | 1 | 2022 | 400 | 0.040 |
Why?
| | Antibodies, Viral | 1 | 2003 | 672 | 0.040 |
Why?
| | Crystallography, X-Ray | 1 | 2020 | 492 | 0.040 |
Why?
| | Methylation | 1 | 2019 | 242 | 0.040 |
Why?
| | Biological Transport | 1 | 2020 | 417 | 0.040 |
Why?
| | Infant, Small for Gestational Age | 1 | 2020 | 109 | 0.040 |
Why?
| | Glucose Intolerance | 1 | 2020 | 142 | 0.040 |
Why?
| | Sheep | 1 | 2021 | 880 | 0.040 |
Why?
| | Interferons | 1 | 2020 | 188 | 0.040 |
Why?
| | Adaptation, Physiological | 1 | 2003 | 570 | 0.040 |
Why?
| | Molecular Weight | 1 | 2019 | 327 | 0.040 |
Why?
| | Citric Acid Cycle | 1 | 2018 | 59 | 0.040 |
Why?
| | Fibrinogen | 2 | 2010 | 177 | 0.040 |
Why?
| | Cilia | 1 | 2020 | 173 | 0.040 |
Why?
| | Molecular Dynamics Simulation | 1 | 2020 | 259 | 0.040 |
Why?
| | Lymphocyte Count | 1 | 2018 | 164 | 0.040 |
Why?
| | Cyclooxygenase 2 | 1 | 2019 | 165 | 0.040 |
Why?
| | Microglia | 1 | 2021 | 268 | 0.030 |
Why?
| | Germinal Center | 1 | 2018 | 67 | 0.030 |
Why?
| | GTP Phosphohydrolases | 1 | 2018 | 93 | 0.030 |
Why?
| | Metagenomics | 1 | 2020 | 181 | 0.030 |
Why?
| | Animals, Newborn | 1 | 2021 | 902 | 0.030 |
Why?
| | Caspase 1 | 1 | 2018 | 148 | 0.030 |
Why?
| | Models, Molecular | 1 | 2003 | 1618 | 0.030 |
Why?
| | Native Polyacrylamide Gel Electrophoresis | 1 | 2018 | 3 | 0.030 |
Why?
| | Naphthoquinones | 1 | 2018 | 19 | 0.030 |
Why?
| | Fluorescent Antibody Technique | 1 | 2019 | 370 | 0.030 |
Why?
| | Methionine | 1 | 2018 | 162 | 0.030 |
Why?
| | Ultrasonography, Prenatal | 1 | 2020 | 294 | 0.030 |
Why?
| | Phospholipase A2 Inhibitors | 1 | 2017 | 3 | 0.030 |
Why?
| | Immunoprecipitation | 1 | 2018 | 151 | 0.030 |
Why?
| | Predictive Value of Tests | 2 | 2015 | 2115 | 0.030 |
Why?
| | Proportional Hazards Models | 1 | 2021 | 1325 | 0.030 |
Why?
| | Bone Marrow Cells | 1 | 2018 | 320 | 0.030 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2018 | 169 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2021 | 1539 | 0.030 |
Why?
| | Lysine | 1 | 2019 | 302 | 0.030 |
Why?
| | Energy Intake | 1 | 2020 | 499 | 0.030 |
Why?
| | Nutritional Status | 1 | 2020 | 354 | 0.030 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2024 | 1720 | 0.030 |
Why?
| | Forensic Medicine | 1 | 2017 | 17 | 0.030 |
Why?
| | Transfection | 1 | 2019 | 940 | 0.030 |
Why?
| | Toll-Like Receptor 9 | 1 | 2017 | 37 | 0.030 |
Why?
| | Fetus | 1 | 2021 | 803 | 0.030 |
Why?
| | Weight Loss | 1 | 2022 | 836 | 0.030 |
Why?
| | Catalytic Domain | 1 | 2018 | 232 | 0.030 |
Why?
| | RNA, Messenger | 2 | 2017 | 2832 | 0.030 |
Why?
| | Gene Knockdown Techniques | 1 | 2018 | 336 | 0.030 |
Why?
| | Pregnancy Outcome | 1 | 2020 | 476 | 0.030 |
Why?
| | Circadian Rhythm | 1 | 2021 | 514 | 0.030 |
Why?
| | Caloric Restriction | 1 | 2018 | 127 | 0.030 |
Why?
| | Tissue Donors | 1 | 2019 | 424 | 0.030 |
Why?
| | Gestational Age | 1 | 2020 | 975 | 0.030 |
Why?
| | RNA-Binding Proteins | 2 | 2011 | 462 | 0.030 |
Why?
| | Family | 1 | 2021 | 679 | 0.030 |
Why?
| | Influenza A virus | 1 | 2017 | 113 | 0.030 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2021 | 1217 | 0.030 |
Why?
| | Escherichia coli | 1 | 2020 | 854 | 0.030 |
Why?
| | Methemoglobin | 1 | 2015 | 24 | 0.030 |
Why?
| | Structure-Activity Relationship | 1 | 2017 | 570 | 0.030 |
Why?
| | Gene Regulatory Networks | 1 | 2018 | 318 | 0.030 |
Why?
| | DNA Damage | 1 | 2019 | 430 | 0.030 |
Why?
| | Body Mass Index | 2 | 2015 | 2438 | 0.030 |
Why?
| | Immunoglobulin M | 1 | 2017 | 284 | 0.030 |
Why?
| | Hydrogen Peroxide | 1 | 2017 | 336 | 0.030 |
Why?
| | Clone Cells | 1 | 2016 | 266 | 0.030 |
Why?
| | Etiocholanolone | 1 | 2015 | 6 | 0.030 |
Why?
| | Cystic Fibrosis | 1 | 2025 | 1158 | 0.030 |
Why?
| | Ranolazine | 1 | 2015 | 25 | 0.030 |
Why?
| | Trihexosylceramides | 1 | 2015 | 4 | 0.030 |
Why?
| | Gerbillinae | 1 | 2015 | 72 | 0.030 |
Why?
| | Thiocyanates | 1 | 2015 | 28 | 0.030 |
Why?
| | Elasticity | 1 | 2015 | 184 | 0.030 |
Why?
| | Severity of Illness Index | 2 | 2015 | 2925 | 0.030 |
Why?
| | Placenta | 1 | 2021 | 780 | 0.030 |
Why?
| | Genome-Wide Association Study | 1 | 2021 | 1406 | 0.030 |
Why?
| | Pulse Wave Analysis | 1 | 2015 | 266 | 0.030 |
Why?
| | Cardiotonic Agents | 1 | 2015 | 95 | 0.030 |
Why?
| | Chronic Disease | 1 | 2020 | 1813 | 0.030 |
Why?
| | Genomics | 1 | 2020 | 834 | 0.030 |
Why?
| | Mitochondria, Heart | 1 | 2015 | 102 | 0.030 |
Why?
| | Prospective Studies | 2 | 2021 | 7990 | 0.030 |
Why?
| | Brachial Artery | 1 | 2015 | 206 | 0.030 |
Why?
| | Molecular Targeted Therapy | 1 | 2017 | 432 | 0.030 |
Why?
| | Immunity, Innate | 1 | 2020 | 846 | 0.030 |
Why?
| | Host-Pathogen Interactions | 1 | 2017 | 371 | 0.030 |
Why?
| | Incidence | 1 | 2021 | 2879 | 0.030 |
Why?
| | Child, Preschool | 1 | 2009 | 11787 | 0.030 |
Why?
| | Salmeterol Xinafoate | 1 | 2013 | 20 | 0.030 |
Why?
| | Fluticasone | 1 | 2013 | 53 | 0.030 |
Why?
| | Cyclopropanes | 1 | 2013 | 83 | 0.020 |
Why?
| | Pregnenolone | 1 | 2013 | 3 | 0.020 |
Why?
| | Time Factors | 2 | 2019 | 7173 | 0.020 |
Why?
| | Androstadienes | 1 | 2013 | 76 | 0.020 |
Why?
| | Immune Tolerance | 1 | 2016 | 379 | 0.020 |
Why?
| | Albuterol | 1 | 2013 | 73 | 0.020 |
Why?
| | Acetates | 1 | 2013 | 80 | 0.020 |
Why?
| | Disease Progression | 1 | 2021 | 2847 | 0.020 |
Why?
| | Leukocyte Count | 1 | 2013 | 316 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2017 | 2027 | 0.020 |
Why?
| | Sulfides | 1 | 2013 | 91 | 0.020 |
Why?
| | Statistics, Nonparametric | 1 | 2013 | 427 | 0.020 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2013 | 341 | 0.020 |
Why?
| | Colorado | 1 | 2022 | 4564 | 0.020 |
Why?
| | Adenosine Triphosphate | 1 | 2015 | 498 | 0.020 |
Why?
| | Interleukin-4 | 1 | 2013 | 206 | 0.020 |
Why?
| | Vasodilation | 1 | 2015 | 523 | 0.020 |
Why?
| | Forced Expiratory Volume | 1 | 2013 | 449 | 0.020 |
Why?
| | Quinolines | 1 | 2013 | 193 | 0.020 |
Why?
| | Energy Metabolism | 1 | 2018 | 935 | 0.020 |
Why?
| | Interleukin-2 | 1 | 2013 | 437 | 0.020 |
Why?
| | Genetic Association Studies | 1 | 2013 | 372 | 0.020 |
Why?
| | Mesocricetus | 1 | 2011 | 46 | 0.020 |
Why?
| | Fas Ligand Protein | 1 | 2011 | 60 | 0.020 |
Why?
| | Antioxidants | 1 | 2015 | 549 | 0.020 |
Why?
| | Anti-Bacterial Agents | 1 | 2022 | 1907 | 0.020 |
Why?
| | Cell Line, Transformed | 1 | 2011 | 140 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2026 | 11679 | 0.020 |
Why?
| | Cricetinae | 1 | 2011 | 303 | 0.020 |
Why?
| | Eosinophils | 1 | 2013 | 316 | 0.020 |
Why?
| | Antigen-Presenting Cells | 1 | 2011 | 160 | 0.020 |
Why?
| | Regression Analysis | 1 | 2013 | 1003 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 851 | 0.020 |
Why?
| | Salts | 1 | 2010 | 37 | 0.020 |
Why?
| | Nitric Oxide | 1 | 2015 | 897 | 0.020 |
Why?
| | Adrenal Cortex Hormones | 1 | 2013 | 478 | 0.020 |
Why?
| | Myocytes, Cardiac | 1 | 2015 | 556 | 0.020 |
Why?
| | Spectrophotometry, Ultraviolet | 1 | 2010 | 85 | 0.020 |
Why?
| | HLA-A Antigens | 1 | 2010 | 52 | 0.020 |
Why?
| | Surgical Tape | 1 | 2009 | 5 | 0.020 |
Why?
| | Administration, Inhalation | 1 | 2011 | 574 | 0.020 |
Why?
| | Endothelin-Converting Enzymes | 1 | 2009 | 10 | 0.020 |
Why?
| | Fibrin | 1 | 2010 | 91 | 0.020 |
Why?
| | Aspartic Acid Endopeptidases | 1 | 2009 | 32 | 0.020 |
Why?
| | Interferon-gamma | 1 | 2013 | 784 | 0.020 |
Why?
| | Metalloendopeptidases | 1 | 2009 | 62 | 0.020 |
Why?
| | Thrombin | 1 | 2010 | 166 | 0.020 |
Why?
| | alpha-2-HS-Glycoprotein | 1 | 2009 | 2 | 0.020 |
Why?
| | Immunoglobulin J-Chains | 1 | 2009 | 6 | 0.020 |
Why?
| | Amino Acid Motifs | 1 | 2010 | 224 | 0.020 |
Why?
| | Pulmonary Surfactant-Associated Protein A | 1 | 2009 | 29 | 0.020 |
Why?
| | Mice, Mutant Strains | 1 | 2009 | 299 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2020 | 5868 | 0.020 |
Why?
| | Haptoglobins | 1 | 2009 | 66 | 0.020 |
Why?
| | Risk | 1 | 2011 | 911 | 0.020 |
Why?
| | Albumins | 1 | 2009 | 118 | 0.020 |
Why?
| | Phosphotyrosine | 1 | 2008 | 39 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2020 | 6429 | 0.020 |
Why?
| | alpha 1-Antitrypsin | 1 | 2009 | 102 | 0.020 |
Why?
| | Endothelin-1 | 1 | 2009 | 184 | 0.020 |
Why?
| | Drug Interactions | 1 | 2009 | 398 | 0.020 |
Why?
| | src-Family Kinases | 1 | 2008 | 93 | 0.020 |
Why?
| | Databases, Factual | 1 | 2013 | 1486 | 0.020 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2008 | 173 | 0.020 |
Why?
| | Nanotechnology | 1 | 2008 | 126 | 0.020 |
Why?
| | Blood Proteins | 1 | 2009 | 249 | 0.020 |
Why?
| | Protein Conformation | 1 | 2010 | 946 | 0.020 |
Why?
| | Lymphoma | 1 | 2008 | 232 | 0.020 |
Why?
| | Staphylococcus aureus | 1 | 2011 | 455 | 0.020 |
Why?
| | Cell Cycle | 1 | 2009 | 596 | 0.020 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2011 | 905 | 0.010 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2008 | 436 | 0.010 |
Why?
| | Age Factors | 1 | 2013 | 3333 | 0.010 |
Why?
| | Cell Membrane | 1 | 2009 | 706 | 0.010 |
Why?
| | Algorithms | 1 | 2013 | 1837 | 0.010 |
Why?
| | Histones | 1 | 2010 | 669 | 0.010 |
Why?
| | Immunoglobulin G | 1 | 2009 | 893 | 0.010 |
Why?
| | Promoter Regions, Genetic | 1 | 2009 | 1257 | 0.010 |
Why?
| | United States | 1 | 2022 | 15966 | 0.010 |
Why?
| | Pyrimidines | 1 | 2008 | 532 | 0.010 |
Why?
| | Gene Expression Profiling | 1 | 2011 | 1782 | 0.010 |
Why?
| | Raffinose | 1 | 2003 | 29 | 0.010 |
Why?
| | Germination | 1 | 2003 | 8 | 0.010 |
Why?
| | Tomography, X-Ray Computed | 1 | 2013 | 2730 | 0.010 |
Why?
| | Sucrose | 1 | 2003 | 112 | 0.010 |
Why?
| | T-Lymphocytes | 1 | 2010 | 1982 | 0.010 |
Why?
| | Vaccination | 1 | 2010 | 1423 | 0.010 |
Why?
| | Antibodies, Monoclonal | 1 | 2008 | 1519 | 0.010 |
Why?
| | Risk Factors | 1 | 2015 | 10779 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 2011 | 6048 | 0.010 |
Why?
|
|
Reisdorph's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|